FRONTEO, Inc.

2158・Growth Market・Services

Official website

FRONTEO, Inc.

2158・Growth Market・Services

Official website

FRONTEO, Inc.2158

2158Growth MarketServices

1st Quarter of FY2027/3Earnings Call

Launch of KIBIT AI Biology Lab and commercialization of bio-simulation highlighted; next catalysts are securing at least one US deal within the fiscal year and progress on out-licensing pipeline

August 14, 2026 at 22:10 GMT+9

2158Growth MarketServices

1st Quarter of FY2027/3Earnings Release

Revenue Growth Driven By AI Drug Discovery and Alnetz, But Operating Loss Widens. Full-Year Operating Income of JPY 300M Is Back-End Loaded; AI Drug Discovery Out-Licensing Is The Key

August 14, 2026 at 20:20 GMT+9

2158Growth MarketServices

1st Quarter of FY2027/3Earnings Preview

Focus on AI drug discovery co-creation project pipeline build-up, progress in business portfolio restructuring, and profitability during the upfront investment phase

August 12, 2026 at 15:30 GMT+9